Legislation with proposals that drug firms were hesitant to get behind – reforming FDA's OTC drug monograph program and establishing a user fee program to support the agency's work – is close to surfacing in Congress with the industry's backing.
A separate change also requiring legislation but that the industry has backed from the start, eliminating the Affordable Care Act...







